Eiger Biopharmaceuticals Com News - CLDN

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:filename1.pdf

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...

Statement of Ownership (sc 13g)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Celladon Sets Date for Special Meeting of Stockholders

SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today it has set...

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Table of Contents As filed with the Securities and Exchange Commission on February 8, 2016...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Table of Contents As filed with the Securities and Exchange Commission on January 22, 2016 Registration...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Eiger Biopharmaceuticals Com (CLDN)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CLDN News

Confidential Treatment Order (ct Order)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Notice of Effectiveness (effect)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Celladon Sets Date for Special Meeting of Stockholders

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Statement of Ownership (sc 13g)

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Current Report Filing (8-k)

CLDN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Eiger Biopharmaceuticals Com (CLDN) News

Eiger Biopharmaceuticals Com (CLDN)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CLDN News

Confidential Treatment Order (ct Order)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Notice of Effectiveness (effect)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Celladon Sets Date for Special Meeting of Stockholders

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Statement of Ownership (sc 13g)

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Current Report Filing (8-k)

CLDN Discussion

Your Recent History